Biocatalysis for APIs and intermediates
When an enzyme or a whole cell takes the place of a chemical step. This is the area where the catalyst is chosen, the reaction is designed, and it is decided whether the enzyme works free or immobilised.
Tell us about your reactionA reaction that has to cost less, or pollute less
Biocatalysis is chosen for selectivity, for milder conditions or for a better environmental profile. But it only pays if the catalyst holds for the number of cycles the economics require — and that is what gets measured.
You have a chemical step to replace
Poor selectivity, harsh conditions, by-products to dispose of. It starts from feasibility: does an enzyme exist that performs that transformation, and under which conditions.
You have an enzyme that works once
In batch it is fine, but the cost of the biocatalyst per kilo of product does not add up. This is where immobilisation changes the economics of the reaction.
You have a reaction to take continuous
Flow or packed-bed reactor: it takes a suitable support, measured kinetics and operational stability over time.
The services in this area
Two services chosen in sequence: first the reaction, then the form the catalyst works in.
The biocatalytic steps with the greatest impact in pharma
- Stereoselective reductions →: ketones reduced with ketoreductases and alcohol dehydrogenases, with cofactor regeneration: chiral alcohols for APIs and intermediates.
- Transaminations →: ω-transaminases for chiral amines from the corresponding ketones.
- Kinetic resolutions and desymmetrisations →: lipases and esterases for enantiopure alcohols, acids and esters.
- Selective oxidations →: oxygen-dependent enzymes, monooxygenases and oxidases, flow reactors included.
- Amides and nitriles →: acylases, amidases, nitrilases and nitrile hydratases.
- Integrated chemo-enzymatic processes →: the enzymatic step built into the chemical synthesis, in place of one or more steps with protection and deprotection.
What we measure
The numbers on which it is decided whether a biocatalytic route really replaces the chemical one.
- Conversion and selectivity — how much substrate becomes product, and how much becomes something else
- Enantiomeric excess — where chirality is the reason the enzyme was chosen in the first place
- Specific activity — activity per unit of biocatalyst, free and immobilised
- Number of cycles — how many times the immobilised catalyst is reused before it drops below threshold
- Operational stability — residual activity over time, under real reaction conditions
- Space-time yield — product per litre of reactor and per hour
- Biocatalyst cost — per kilo of product, which is the number the decision rests on
- Behaviour in flow — bed integrity and pressure drop, when the reaction goes continuous
Techno-economic assessment
The cost is worked out after screening, not at the end. With the first-stage data we calculate cost per kilogram against the process in use: biocatalyst and number of cycles, solvent and recovery, downstream separations, energy. It is done halfway through the investment, while there is still time to decide whether to go on. Every stage has go/no-go criteria stated before it starts.
Equipment for this area
| Reaction | Thermostatted bioconversion reactors with pH and temperature control, and packed-bed flow trials |
| Immobilisation | Different supports and binding chemistries, with comparative screening of immobilisation conditions |
| Analytics | Preparative HPLC and UPLC, GC with mass spectrometry and headspace, SEC, SDS-PAGE, spectrophotometers and titrators |
| Screening | A.L.EX, the robotic platform for high throughput screening, up to 40,000 samples a day |
| Techniques in partnership | NMR with a qualified external partner, when structural confirmation is needed |
Frequently asked questions
From a target molecule, a chemical transformation, an existing process or an enzyme or microorganism already identified.
Enzyme and microorganism screening, biocatalyst development, bioconversion optimisation, downstream and scale-up, with go/no-go criteria at every stage.
When you need selectivity, milder conditions or less waste, and the biocatalyst lasts the cycles the economics require: we check it with a techno-economic assessment halfway through.
Let us talk about the step you want to replace
Tell us which chemical step it is and the constraints you work under: we will tell you whether an enzymatic route makes sense and how to check.
Tell us about your reaction